
Danaher
Price
Price
CHART BY
Historical dividends and forecast
Danaher has so far distributed $0.27 in 2025. The next dividend will be paid on 25.04.2025
CHART BY
Frequently asked questions
What is Danaher's market capitalization?
What is Danaher's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for Danaher?
What are the analyst ratings and target price for Danaher's stock?
What is Danaher's revenue over the trailing twelve months?
Is Danaher paying dividends?
What is the EBITDA for Danaher?
What is the free cash flow of Danaher?
How many employees does Danaher have, and what sector and industry does it belong to?
What is the free float of Danaher's shares?
Financials
- Market Cap
- $147.28B
- EPS (TTM)
- $5.288
- Free Float
- 648.54M
- P/E ratio (TTM)
- 38.92
- Revenue (TTM)
- $23.88B
- EBITDA (TTM)
- $7.54B
- Free Cashflow (TTM)
- $5.30B
Pricing
- 1D span
- $199.17$206.09
- 52W span
- $196.87$281.38
Analyst Ratings
The price target is $264.87 and the stock is covered by 30 analysts.
Buy
25
Hold
5
Sell
0
Information
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
- Employees
- 63,000
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- ISIN
- US2358511028
- Primary Ticker
- DHR